← Back to patent-cliff list
CAS 351329-88-9
N-((1r,3R,5S,7r)-3,5-dimethyladamantan-1-yl)formamide
Codes: MEMA-006
Application context (from source-drug indications)
Alzheimer's diseaseMemantine Hydrochloride/Donepezil HydrochlorideAlzheimer's diseaseMemantine HydrochlorideTraumatic brain injuryMemantine HydrochlorideTrichotillomaniaMemantine HydrochlorideSchizophreniaMemantine HydrochlorideLung cancerMemantine HydrochlorideSmall cell lung cancerMemantine Hydrochloride
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Memantine Hydrochloride/Donepezil Hydrochloride | Tier C — Watch / trade | - |
| Memantine Hydrochloride | Tier B — Position early | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
(1r,3R,5S,7r)-3,5-dimethyladamantan-1-ol→(1r,3R,5S,7r)-1-chloro-3,5-dimethyladamantane→N-((1r,3R,5S,7r)-3,5-dimethyladamantan-1-yl)formamide→(1r,3r,5s,7s)-1,3-dimethyladamantane
(1r,3R,5S,7r)-3,5-dimethyladamantan-1-ol→(1r,3R,5S,7r)-1-chloro-3,5-dimethyladamantane→N-((1r,3R,5S,7r)-3,5-dimethyladamantan-1-yl)formamide→(1r,3r,5s,7s)-1,3-dimethyladamantane
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.